|
Volumn 150, Issue 2, 2004, Pages 379-380
|
Successful treatment of acrodermatitis continua of Hallopeau by the tumour necrosis factor-α inhibitor infliximab (Remicade®) [10]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
CALCIPOTRIOL;
CYCLOSPORIN;
ETRETIN;
GLUCOCORTICOID;
INFLIXIMAB;
TUMOR NECROSIS FACTOR ALPHA INHIBITOR;
UNCLASSIFIED DRUG;
ACRODERMATITIS;
ACRODERMATITIS CONTINUA OF HALLOPEAU;
ADULT;
CASE REPORT;
CLINICAL FEATURE;
ERYTHEMA;
HUMAN;
LETTER;
MALE;
NAIL DYSTROPHY;
PRIORITY JOURNAL;
PUSTULE;
SIDE EFFECT;
ACRODERMATITIS;
ANTIBODIES, MONOCLONAL;
DERMATOLOGIC AGENTS;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASM PROTEINS;
RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II;
TREATMENT OUTCOME;
TUMOR NECROSIS FACTOR DECOY RECEPTORS;
|
EID: 1542402002
PISSN: 00070963
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1365-2133.2003.05761.x Document Type: Letter |
Times cited : (27)
|
References (9)
|